# RET
Companion code to the paper "The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers"

The codes and data used in the analysis of WES, MSK-IMPACT, and MSK-ACCESS sequencing data will be deposited and available at the time of paper publication.

Additionally, comprehensive clinical and genomic data are available at http://private.cbioportal.org/private/study/summary?id=mixed_selpercatinib_2020 which will be available publically at the time of paper publication.
